When: Confirmed close above 50 SMA at $102.45 with sustained momentum

Then: Add 10-15% of target weight

HOLD with small starter position of 25-40% of target weight; wait for technical confirmation (daily close above 50 SMA at 102.45 with rising RSI, or confirmed retest/hold of lower Bollinger band at 90.00 with bullish reversal candle); tighten stop to 91.50 on 50 SMA retest; hedge rate exposure with TLT put or pair trade

• MACD line at negative 2.65, signal line at negative 2.52, histogram still negative indicating bearish momentum deceleration not reversal
• RSI at 30.86 can stay in 25-35 zone for weeks in established declines, not a reversal trigger
• Price below all three moving averages: 10 EMA at 95.52, 50 SMA at 102.45, 200 SMA at 97.78
• 10 EMA below 50 SMA is death cross precursor indicating confirmed structural downtrend
• Forward P/E of 30x assumes EPS recovery from 1.73 to 3.12 (80% increase) that is NOT YET REALIZED; trailing P/E of 54.8x shows actual current valuation
• Dividend payout ratio at 152% on depressed EPS makes dividend at risk; 2.64% yield becomes a trap if dividend cut
• Gross margin compressed from historical 27% to current 22.3% (470 basis points), structurally less profitable
• EBITDA margin at 14.7% versus historical levels north of 18%
• Net debt reduced from 22.4B to 9.8B but deleveraging benefits equity holders ONLY when converted to buybacks
• Q2-FY26 operating income of 1.2B includes 536M gain on sale; underlying operating income around 670M comparable to Q3-FY25's 278M normalized for 755M restructuring charge
• Revenue declined 1.4% year-over-year in most recent quarter
• Buybacks halted with no announced resumption date or filing commitment, pure speculation
• 97% probability on Polymarket of no rate cuts in 2026 keeps discount rate elevated through 2027
• Risk-off money rotating into AI/IT names (IBM, Accenture, Micron, Synopsys) NOT consumer cyclical
• Conservative expected value: 0.6 probability of 8.50 gain to 102, 0.3 probability of 14.50 gain to 108, 0.4 probability of 5.00 loss to 88.50 = net +5.85
• Position sizing of 75-100% target weight is inappropriate given unconfirmed fundamentals, active downtrend, and macro headwinds

→ vs aggressive: MACD histogram at negative 0.13 does NOT signal bullish reversal; requires histogram to cross above zero while price makes lower low. Current compression is deceleration in active downtrend, not exhaustion.

→ vs aggressive: RSI at 30.86 is not 'one tick away from oversold' as a reversal trigger; RSI can stay in 25-35 zone for weeks in established declines.

→ vs aggressive: Entry at 97.99 is buying into a downtrend with no technical confirmation it has ended; price is below all three major moving averages.

→ vs aggressive: 30x forward P/E is speculation priced as valuation; assumes 80% earnings increase not yet realized. Trailing P/E of 54.8x tells the actual story of current earnings power.

→ vs aggressive: Dividend at 152% payout ratio and 2.64% yield is a yield trap if dividend is cut due to restructuring pressure; dividend sustainability risk completely ignored.

→ vs aggressive: Margin compression from 27% to 22.3% and EBITDA margin at 14.7% vs 18%+ historical are structural, not temporary transition costs.

→ vs aggressive: Buyback resumption is pure speculation with no announced date or filing commitment; management may not resume until 2026 or 2028.

→ vs aggressive: China divestiture removes growth optionality from a market that was supposed to be the long-term compounder; 'recovery' in operating income is artificially boosted by 536M one-time gain.

→ vs aggressive: 10Y at 2002 highs with 97% probability of no rate cuts in 2026 means multiple expansion assumption is wrong; 30x P/E expensive in 5% risk-free environment.

→ vs aggressive: Risk-on sessions show money rotating into AI/IT names, NOT consumer cyclical; fighting sector rotation headwind.

→ vs aggressive: Risk/reward arithmetic assumes 100% probability of hitting targets; conservative 60%/30%/40% probability framework shows expected value of +5.85 vs aggressive's misleading full-probability math.

→ vs aggressive: Position sizing of 75-100% of target weight is not bold positioning but inappropriate risk exposure; 25-50% maximum is disciplined risk management.

moderate long; 40 to 55 percent of target weight with staggered accumulation and defined add-on triggers; 88.50 stop tightened to 91 on daily close below 90; 1 to 2 percent macro hedge via TLT puts or pair trade recommended

• Technical setup has merit (RSI 30.86, lower Bollinger band at 90, MACD compression) but aggressive analyst overshoots calling negative 0.13 histogram a confirmed bullish divergence
• Buyback resumption is not announced or committed in filings; building bull case on unconfirmed future event is narrative-driven rather than evidence-driven
• China derisking ($2.54B cash inflow) simplifies the business but removes long-term growth optionality in international segment; both analyst views on this are partially correct
• Death cross risk, price below all major moving averages, 152% dividend payout ratio, 470 basis point gross margin compression, and 54.8x trailing P/E are all genuine concerns warranting caution
• Conservative analyst's entry timing is too rigid; waiting for full confirmation (daily close above 50 SMA at 102.45 with rising RSI) flips risk/reward unfavorably
• Conservative analyst's probability framework is biased pessimistic: 40% stop-out probability too high given lower Bollinger band proximity, 30% extension to 108 probability too low given historical oversold bounce patterns
• Dividend cut unlikely near-term; on free cash flow basis dividend is only 75% covered which is manageable; dividend cut would be major sell signal requiring immediate exit
• Macro risk severely underweighted by both analysts; 10Y at 2002 highs with 97% probability of no 2026 rate cuts is structural headwind requiring hedge, not dismissal
• Staggered accumulation approach is sound but first tranche must be capped at 25 to 30 percent rather than aggressive analyst's 75 percent straight entry
• 25 to 40 percent target weight is worst of both worlds; either commit meaningfully or stay out; middle ground invites whipsaw and worse cost basis

→ vs aggressive: MACD histogram reading of negative 0.13 does not constitute confirmed bullish divergence; divergence requires price making lower low while indicator makes higher low, neither of which has occurred; current reading shows deceleration of selling, not confirmed reversal

→ vs aggressive: Buyback pipeline argument has no announced date or management commitment in filings; capital return thesis is hope, not analysis; this is the central pillar of bull case built on unconfirmed future event

→ vs aggressive: China derisking removes growth optionality alongside simplifying the business; market must reprice growth profile lower for smaller international footprint; ignoring this structural change is analytical error

→ vs conservative: Waiting for full confirmation before adding meaningfully results in buying at 100+ with risk/reward flipped to 1 to 0.7; optimizing for being right rather than making money is a classic mistake

→ vs conservative: Probability framework is more pessimistic than base rates support; 40% probability to stop-out at 88.50 is too high given multi-quarter support and lower Bollinger band proximity; 30% probability to extension to 108 is too low given historical oversold bounce patterns in quality names

→ vs conservative: HOLD recommendation of 25 to 40 percent target weight is worst of both worlds; too much for fundamental skeptic, too little for someone seeing genuine opportunity; either commit or exit, middle ground invites whipsaw

→ vs conservative: Acknowledged macro risk but proposed no structural hedge; 10Y at 2002 highs and zero 2026 rate cut probability warrants active hedging via TLT puts or pair trade, not passive acknowledgment